Symbol
|
FTGEFG | QNGLTQ | QSCLTQ | ALSRCH | JCIRCH | JVJRCH | LGWRCH | WEVLTQ | RMASWV | RMASRV | RMAV9V | RMAX4V | XRMLTQ | AAUYSQ | Z23CGZ | SAHUJB | RMADSV | RMBBNV | ABBZSQ | RMBWDV |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nom | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Multi Reverse Convertible | Multi Vonti | Multi Vonti | Multi Vonti | Multi Vonti | Worst of Reverse Convertible | Reverse Convertible | ZKB Reverse Convertible on worst of Last Look | Reverse Convertible | Multi Vonti | Multi Vonti | Reverse Convertible | Multi Vonti |
Sous-jacent
|
Nestlé S.A. / Novartis Sandoz Basket / Roche AG / UBS Group AG / Zurich Insurance Group AG | ABB LTD-REG ACCELLERON INDUSTRIES Ltd. / Nestlé S.A. / Novartis Sandoz Basket / Roche AG / UBS Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / UBS Group AG / Zurich Insurance Group AG | Holcim AG / Julius Baer Group / Swatch Group I / UBS Group AG / UBS Group Basket | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / UBS Group AG / Zurich Insurance Group AG | Roche AG / Swiss RE AG / Swisscom N / UBS Group AG | ABB N / Nestlé N / Roche GS / UBS Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / UBS Group AG / Zurich Insurance Group AG | Nestlé N / Roche GS / Swiss RE AG / UBS Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Swiss RE AG / UBS Group AG | LafargeHolcim Ltd. / Roche GS / Swisscom N / UBS Group AG / Zurich Insurance Group AG | LafargeHolcim Ltd. / Nestlé N / Roche GS / UBS Group AG | Mitsubishi UFJ Financial Group Inc. / UBS Group AG | Swiss Life Hldg. N / Swiss RE AG / UBS Group AG / Zurich Insurance Group AG | Komax AG / Lonza Group N / UBS Group AG | UBS Group AG | Companie Financière Richemont SA / LafargeHolcim Ltd. / Nestlé N / Novartis N / UBS Group AG | Partners Group Hldg. AG / UBS Group AG | Roche GS / Swisscom / UBS | Nestlé / Novartis / Roche GS / UBS / Zurich |
Emetteur
|
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Échéance
|
26.08.2024 | 19.05.2025 | 03.12.2024 | 27.09.2024 | 24.09.2024 | 04.09.2024 | 16.12.2024 | 31.03.2028 | 10.02.2025 | 10.02.2026 | 17.02.2026 | 24.02.2025 | 06.07.2026 | 18.08.2025 | 06.09.2024 | 12.09.2024 | 10.11.2025 | 17.11.2025 | 01.12.2025 | 27.07.2026 |
Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0,021303 | - | - | - | - |
Prix d'exercise
|
58,93 | 64,38 | 67,07 | 38,38 | 82,35 | 10,946 | 20,43 | 71,27 | 211,76 | 61,33 | 32,89 | 39,79 | 17,57 | 269,36 | 16,62 | 21,303 | 64,84 | 735,00 | 166,845 | 282,20 |
rendement max. p.a. | -17,50% | 2,89% | 0,17% | - | 102,44% | -6,30% | 4,41% | 4,11% | 7,90% | - | 5,60% | 5,33% | - | 2,29% | 377,76% | 0,01% | 6,57% | 2,98% | 2,84% | 4,75% |
Demande | 101,30 | 99,00 | 100,65 | 21,820 | 100,16 | 100,55 | 100,71 | 101,60 | 98,90 | 99,10 | 99,50 | 100,50 | 193,51 | 102,26 | 88,40 | 100,05 | 99,80 | 102,50 | 101,99 | 99,90 |
Offre | 102,11 | 99,80 | 101,46 | - | 100,96 | 101,36 | 101,52 | 102,42 | 99,90 | - | 100,30 | 101,30 | 195,06 | 103,08 | 88,90 | 100,55 | 100,60 | 103,30 | 102,81 | 100,70 |